Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case
Mesalazine- (5-aminosalicylic acid-) containing products are a well-known treatment for inflammatory bowel disease, often as first line. Myocarditis is recognized as a very rare possible side effect of this drug treatment. We present a case of mesalazine-induced myopericarditis that was successfully...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Case Reports in Cardiology |
Online Access: | http://dx.doi.org/10.1155/2015/728310 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832545640584839168 |
---|---|
author | Michele Sorleto Stefanie Dürrwald Marcus Wiemer |
author_facet | Michele Sorleto Stefanie Dürrwald Marcus Wiemer |
author_sort | Michele Sorleto |
collection | DOAJ |
description | Mesalazine- (5-aminosalicylic acid-) containing products are a well-known treatment for inflammatory bowel disease, often as first line. Myocarditis is recognized as a very rare possible side effect of this drug treatment. We present a case of mesalazine-induced myopericarditis that was successfully improved by immediate cessation of the medication. |
format | Article |
id | doaj-art-42dbe2fafde646649c0930bdb2384adc |
institution | Kabale University |
issn | 2090-6404 2090-6412 |
language | English |
publishDate | 2015-01-01 |
publisher | Wiley |
record_format | Article |
series | Case Reports in Cardiology |
spelling | doaj-art-42dbe2fafde646649c0930bdb2384adc2025-02-03T07:25:08ZengWileyCase Reports in Cardiology2090-64042090-64122015-01-01201510.1155/2015/728310728310Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a CaseMichele Sorleto0Stefanie Dürrwald1Marcus Wiemer2Department of Cardiology, Johannes-Wesling-Klinikum Minden, Hans-Nolte-Strasse 1, 32429 Minden, GermanyDepartment of Cardiology, Johannes-Wesling-Klinikum Minden, Hans-Nolte-Strasse 1, 32429 Minden, GermanyDepartment of Cardiology, Johannes-Wesling-Klinikum Minden, Hans-Nolte-Strasse 1, 32429 Minden, GermanyMesalazine- (5-aminosalicylic acid-) containing products are a well-known treatment for inflammatory bowel disease, often as first line. Myocarditis is recognized as a very rare possible side effect of this drug treatment. We present a case of mesalazine-induced myopericarditis that was successfully improved by immediate cessation of the medication.http://dx.doi.org/10.1155/2015/728310 |
spellingShingle | Michele Sorleto Stefanie Dürrwald Marcus Wiemer Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case Case Reports in Cardiology |
title | Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case |
title_full | Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case |
title_fullStr | Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case |
title_full_unstemmed | Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case |
title_short | Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn’s Disease: Apropos of a Case |
title_sort | mesalazine induced myopericarditis in a patient with a recent diagnosis of crohn s disease apropos of a case |
url | http://dx.doi.org/10.1155/2015/728310 |
work_keys_str_mv | AT michelesorleto mesalazineinducedmyopericarditisinapatientwitharecentdiagnosisofcrohnsdiseaseaproposofacase AT stefaniedurrwald mesalazineinducedmyopericarditisinapatientwitharecentdiagnosisofcrohnsdiseaseaproposofacase AT marcuswiemer mesalazineinducedmyopericarditisinapatientwitharecentdiagnosisofcrohnsdiseaseaproposofacase |